Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001224982 | SCV001397217 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2022-10-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Pro665Leufs*10) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Leber congenital amaurosis (PMID: 17345604). ClinVar contains an entry for this variant (Variation ID: 952801). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. |
Baylor Genetics | RCV003469395 | SCV004216587 | pathogenic | Bardet-Biedl syndrome 14 | 2023-07-22 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV004697079 | SCV005197444 | likely pathogenic | not provided | 2022-07-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005012637 | SCV005631970 | pathogenic | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2024-05-25 | criteria provided, single submitter | clinical testing |